enGene Therapeutics Financials - Benzinga

enGene Therapeutics Inc

ENGNNASDAQ

Trade with Public

Trade with Public

$1.85

-0.07-3.65%

At close: Sep 9, 5:00 PM EST

$1.85

N/A

After Hours: 4:43 PM EST

Earnings: Q3 2026 Earnings were released on Tue Sep 8th, before the market open

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

enGene Therapeutics Financials

enGene Therapeutics (ENGN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
enGene Holdings Q3 EPS $(0.47) Misses $(0.43) Estimate

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.43) by 9.3 percent. This is a 17.54 percent increase over losses of $(0.57) per share from

Benzinga Newsdesk

PRO
enGene Holdings Q2 EPS $(0.43) Beats $(0.47) Estimate

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.47) by 8.51 percent. This is a 15.69 percent increase over losses of $(0.51) per share from

Benzinga Newsdesk

PRO
enGene Holdings Q1 EPS $(0.44) Beats $(0.58) Estimate

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.58) by 24.53 percent. This is a 8.33 percent increase over losses of $(0.48) per share from

Benzinga Newsdesk

PRO
enGene Holdings Q4 EPS $(0.73) Misses $(0.57) Estimate

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.57) by 28.3 percent. This is a 114.71 percent decrease over losses of $(0.34) per share from

Benzinga Newsdesk

Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump

Avi Kapoor

PRO
enGene Holdings Q3 EPS $(0.57) Misses $(0.51) Estimate

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.51) by 12.87 percent. This is a 78.12 percent decrease over losses of $(0.32) per share from

Benzinga Newsdesk